Fifth INTERMACS annual report: Risk factor analysis from more than 6,000 mechanical circulatory support patients
Fifth INTERMACS annual report: Risk factor analysis from more than 6,000 mechanical circulatory support patients
复制标题
DOI：
10.1016/j.healun.2012.12.004
复制
发表时间：
2013-02-01
影响因子：
8.9
通讯作者：
Young, James B.
中科院分区：
文献类型：
--
作者：
Kirklin, James K.;Naftel, David C.;Young, James B.
机械辅助循环支持机构间登记处（INTERMACS）的第5次年度报告总结并分析了前6年的患者和数据收集。目前的分析包括6000多名患者和连续流泵的更新风险因素。在连续泵中，1年的精算生存率为80%，2年为70%。生活质量指标通常是有利的，不良事件负担可能会影响患者对高级心力衰竭治疗的选择。J Heart Lung Transplant 2013;32：141-156（c）2013年国际心肺移植学会。All rights reserved.
The 5th annual report of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) summarizes and analyzes the first 6 years of patient and data collection. The current analysis includes more than 6000 patients and updated risk factors for continuous flow pumps. Among continuous flow pumps, actuarial survival is 80% at 1 year and 70% at 2 years. Quality of life indicators are generally favorable and adverse event burden will likely influence patient selections of advanced heart failure therapies. J Heart Lung Transplant 2013;32:141-156 (c) 2013 International Society for Heart and Lung Transplantation. All rights reserved.